UPDATE: Oppenheimer Downgrades Anchiano Therapeutics (ANCN) to Perform

November 18, 2019 6:29 AM EST Send to a Friend
(Updated - November 18, 2019 6:36 AM EST)

(update comment)Oppenheimer analyst Leland Gershell downgraded Anchiano Therapeutics (NASDAQ: ANCN) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login